Rocket


News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

OKYO Pharma Ltd Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "News Announcement",
"News Announcement"
10/05/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "News Announcement",
"News Announcement"
08/15/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "News Announcement",
"News Announcement"
07/31/2023 6-K Quarterly results
07/28/2023 6-K Quarterly results
07/28/2023 6-K Quarterly results
07/28/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "News Announcement",
"News Announcement"
07/27/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "News Announcement",
"News Announcement"
05/19/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "News Announcement",
"News Announcement"
05/15/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "News Announcement",
"News Announcement"
05/11/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "News Announcement",
"News Announcement"
05/11/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "News Announcement",
"News Announcement"
05/03/2023 6-K Quarterly results
05/03/2023 6-K Quarterly results
05/03/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "News Announcement",
"News Announcement"
05/02/2023 6-K Quarterly results
04/25/2023 6-K Quarterly results
04/05/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "News Announcement",
"News Announcement"
04/04/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "News Announcement",
"News Announcement"
03/30/2023 6-K Quarterly results
03/29/2023 6-K Quarterly results
03/24/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "News Announcement",
"News Announcement"
03/16/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "News Announcement",
"News Announcement"
03/15/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 March 2023 Commission File Number: 001-41386 OKYO Pharma LTD 9th Floor 107 Cheapside London EC2V 6DN Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101: ☐ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101: ☐ INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K THIS ANNOUNCEMENT SHALL NOT CONSTITUTE AN OFFER TO SE..."
03/15/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "News Announcement",
"News Announcement"
03/14/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "News Announcement",
"News Announcement"
03/13/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "News Announcement",
"News Announcement"
02/28/2023 6-K Quarterly results
02/23/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "News Announcement",
"News Announcement"
02/14/2023 6-K Quarterly results
01/04/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "Corporate deck",
"Corporate deck"
01/03/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "News Announcement",
"News Announcement"
12/30/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 December 2022 Commission File Number: 001-41386 OKYO Pharma LTD 9th Floor 107 Cheapside London EC2V 6DN Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101: ☐ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101: ☐ INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K On December 30, 2022, OKYO Pharma LTD issued a pre...",
"News Announcement",
"Consolidated financial statements for the six-month period ended September 30, 2022"
12/22/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "News Announcement",
"News Announcement"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy